Aspire Private Capital’s Boston Scientific BSX Stock Holding History

Aspire Private Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$885K	Sell	20,741 -65	-0.3%	-$3.53K	0.18%	101
2026 Q1	$1.31M	Buy	+20,806	New	+$1.66M	0.29%	79
2025 Q3	–	Sell	-11,292	Closed	-$1.21M	–	175
2025 Q2	$1.21M	Sell	11,292 -1,975	-15%	-$200K	0.28%	81
2025 Q1	$1.34M	Buy	13,267 +1,135	+9%	+$114K	0.33%	63
2024 Q4	$1.08M	Buy	12,132 +319	+3%	+$28.1K	0.27%	74
2024 Q3	$990K	Buy	11,813 +245	+2%	+$19.3K	0.24%	75
2024 Q2	$891K	Buy	11,568 +2,687	+30%	+$197K	0.23%	74
2024 Q1	$608K	Buy	8,881 +996	+13%	+$64K	0.16%	103
2023 Q4	$456K	Buy	7,885 +773	+11%	+$41.3K	0.14%	103
2023 Q3	$376K	Sell	7,112 -269	-4%	-$14.1K	0.12%	102
2023 Q2	$399K	Buy	7,381 +188	+3%	+$9.82K	0.13%	102
2023 Q1	$360K	Buy	+7,193	New	+$339K	0.12%	105
2022 Q3	–	Sell	-53	Closed	-$2K	–	614
2022 Q2	$2K	Hold	53	–	–	﹤0.01%	481
2022 Q1	$2K	Hold	53	–	–	﹤0.01%	485
2021 Q4	$2K	Hold	53	–	–	﹤0.01%	506
2021 Q3	$2K	Hold	53	–	–	﹤0.01%	479
2021 Q2	$2K	Sell	53 -7	-12%	-$294	﹤0.01%	481
2021 Q1	$2K	Sell	60 -10	-14%	-$378	﹤0.01%	453
2020 Q4	$3K	Hold	70	–	–	﹤0.01%	340
2020 Q3	$3K	Buy	+70	New	+$2.7K	﹤0.01%	336
2020 Q1	–	Sell	-70	Closed	-$3K	–	263
2019 Q4	$3K	Hold	70	–	–	﹤0.01%	338
2019 Q3	$3K	Hold	70	–	–	﹤0.01%	314
2019 Q2	$3K	Hold	70	–	–	﹤0.01%	350
2019 Q1	$3K	Buy	70 +10	+17%	+$382	﹤0.01%	393
2018 Q4	$2K	Buy	+60	New	+$2.18K	﹤0.01%	400

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Aspire Private Capital's BSX Position: Q2 2026 in Review

Aspire Private Capital reduced its Boston Scientific (BSX) stake by 0.31% in Q2 2026, selling an estimated $3.53K and leaving 20,741 shares worth $885K. The position accounts for 0.18% of the portfolio, ranked #101.

Aspire Private Capital first reported a position in BSX in Q4 2018 and has held it in 25 quarters since. The position peaked at $1.34M in Q1 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Aspire Private Capital held 20,741 shares of Boston Scientific worth $885K as of Q2 2026.
Aspire Private Capital sold 65 Boston Scientific shares in Q2 2026, an estimated $3.53K.
Boston Scientific made up 0.18% of Aspire Private Capital's portfolio in Q2 2026, its #101 holding.
Aspire Private Capital first reported a position in Boston Scientific in Q4 2018 and has held it in 25 quarters since.
Aspire Private Capital's Boston Scientific position peaked at $1.34M in Q1 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Aspire Private Capital's 13F filing for Q2 2026, filed 15 Jul 2026.